Animace načítání

Stránka se připravuje...


Na co čekáte? Nečekejte už ani minutu.
Získejte přístup na tento text ještě dnes. Kontaktujte nás a my Vám obratem uděláme nabídku pro Vás přímo na míru.

Právní předpis byl sestaven k datu 12.04.2025.

Zobrazené znění právního předpisu je účinné od 01.10.2015.


Nařízení vlády, kterým se mění nařízení vlády č. 463/2013 Sb., o seznamech návykových látek

243/2015 Sb.

Nařízení vlády

Čl. I  Čl. II

Účinnost Čl. III

INFORMACE

243

NAŘÍZENÍ XXXXX

xx dne 14. xxxx 2015,

kterým xx mění nařízení xxxxx x. 463/2013 Xx., x xxxxxxxxx xxxxxxxxxx xxxxx

Xxxxx xxxxxxxx xxxxx §44c odst. 1 xxxxxx x. 167/1998 Sb., x xxxxxxxxxx xxxxxxx a x xxxxx xxxxxxxxx xxxxxxx xxxxxx, xx xxxxx xxxxxx x. 273/2013 Xx.:

Xx. X

Xxxxxxx x. 4 x xxxxxxxx xxxxx č. 463/2013 Sb., o xxxxxxxxx xxxxxxxxxx xxxxx, xxx:

"Xxxxxxx x. 4 x xxxxxxxx xxxxx x. 463/2013 Sb.

Mezinárodní xxxxxxxxxx název (XXX) x xxxxxx jazyce

Další xxxxxxxxxxx nechráněný název xxxx obecný xxxxx

Xxxxxxxx xxxxx xxxxx XXXXX

Xxxxxxxx

XX-7921

3,4-xxxxxxx-X-{[1-(xxxxxxxxxxxxx)xxxxxxxxxx)]xxxxxx}xxxxxxxx

XX-2201

[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](xxxxxxxx-1-xx)xxxxxxxx

5-XX1

5-(2-xxxxxxxxxxx)xxxxx

XXXXXXX

X-(xxxxxxxxx-1-xx)-1-xxxxxx-1X-xxxxxxx-3-xxxxxxxxxx

xx-XXX

2-xxxxx-1-(4-xxxxxxxxxxxx)xxxxxx-1-xx

xx-XXXX

1-(4-xxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx

25X-XXXXx

2-(4-xxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx

Xxxxxxxxxxxxx

XXX

(2XX)-1-(4-xxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx

Xxxxx-Xxxxxxxxx

1-(8-xxxxxxxxx[1,2x:4,5-x´]xxxxxxx-4-xx)xxxxxx-2-xxxx

Xxxxxxx

2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx)]xxxxx-1-xx

Xxxxxxxxxxxxxxxxxxxxxxxx

2X-X

(4-xxx-2,5-xxxxxxxxxxxxxxxxx)xxxx

25X-XXXXx

2-(4-xxxxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx

Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

2X-X-2

[4-(xxxxxxxxxxxxx)-2,5-xxxxxxxxxxxxxxxxx]xxxx

Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

2X-X-7

[2,5-xxxxxxxxx-4-(xxxxxxxxXxxxxx)xxxxxxxx]xxxx

XX-47,497

2-[(1X,3X)-3-xxxxxxxxxxxxxxxxx]-5-(2-xxxxxxxxxxx-2-xx)xxxxx

XXX-13

(xxxxxxxx-1-xx)[4-(xxxxxxxxx)xxxxxxxx-1-xx]xxxxxxxx

XXXX

1,4-xxxxxxxxxxxxxxxxx

Xxxxxxxxxxxxxxxx

XXX

X,X-xxxxxxx-X-[2-(xxxxx-3-xx)xxxxx]xxxx

Xxxxxxxxxxxxxxxxxx

XXX

(2XX)-1-(2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx

4,4'-XXXX

4-xxxxxx-5-(4-xxxxxxxxxxx)-4,5-xxxxxxx-1,3-xxxxxx-2-xxxx

Xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx

XXXX

3-(1,2-xxxxxxxxxxxxxx)-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x] xxxxxxx-1-xx

3,4-XXXX

1-(3,4-xxxxxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx

Xxxxxxxxxxxxxxxxx

XXX

X[2-(xxxxx-3-xx (xxxxx]-X,X-xxxxxxxxxxxx

XXX

1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx

Xxxxxxxxxxxxxxxxxxxxxxx

XXXX

(2XX)-1-(4-xxxxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx

XXx

1-(4-xxx-2,5-xxxxxxxxxxxxxx)xxxxxx-2-xxxx

Xxxxxxxxxxx

XXX

X-xxxxx-1-xxxxxxxxxxxxxxxxxxx

Xxxxxxxxxx

3-(2-xxxxxxxxxx)xxxxx

4-XX

1-(4-xxxxxxxxxx)xxxxxx-2-xxxx

5X-XXX48

X-(xxxxxxxxx-1-xx)-1-(5-xxxxxxxxxxx)-1X-xxxxxxx-3-xxxxxxxxxx

Xxxxxxxxx

1-(4-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx

4-XXX

1-(4-xxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx

3-XXX

1-(3-xxxxxxxxxx)-2-(xxxxxxxxxxx)xxxxxx-1-xx

5XXX-144

[1-(5-xxxxxxxxxxx)-1X-xxxxx-3-xx](2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx

251-XXXXx

2-(4-xxx-2,5-xxxxxxxxxxxxxx)-X-[(2-xxxxxxxxxxxx)xxxxxx]xxxxxxxxx

XXX-018

(xxxxxxxx-1-xx)(1-xxxxxx-1X-xxxxx-3-xx)xxxxxxxx

XXX-073

(1-xxxxx-1X-xxxxx-3-xx)(xxxxxxxx-1-xx)xxxxxxxx

XXX-081

(4-xxxxxxxxxxxxxxx-1-xx)(1 -pentyl-1H-indol-3-yl)methanon

JWH-122

(4-methylnaftalen-1-yl)(1-pentyl-1H-indol-3-y)methanon

JWH-200

[1-(2-morfolinoethyl)-1H-indol-3-yl](naftalen-1-yl)methanon

JWH-250

2-(2-methoxyfenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-on

JWH-398

(4-chlornaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon

Kathinon

(2S)-2-amino-1-fenylpropan-1-on

(+)-Lysergid

LSD, XXX-25

(+)-8β-(3,3-xxxxxxxxxxxxxx)-6-xxxxxx-9,10-xxxxxxxxxxxxxxxx

4-Xxxxxxxxxxxx

(2XX)-1-(4-xxxxxxxxxxx)xxxxxx-2-xxxx

XXXX

1-xxxxxx-4-xxxxxxxxxxxxxxx

xXXX

1-(3-xxxxxxxxxx)xxxxxxxxx

XXXX

5,6-(xxxxxxxxxxxxx)xxxxx-2-xxxx

XXXX

1-[3,4-(xxxxxxxxxxxxx)xxxxx]-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx

3-XXX

2-(xxxxxxxxxx)-1-(3-xxxxxxxxxxx)xxxxxx-1-xx

4-XXX

2-(xxxxxxxxxx)-1-(4-xxxxxxxxxxx)-xxxxxx-1-xx

Xxxxxxxx

2-(xxxxxxxxxxx)-1-(4-xxxxxxxxxxx)xxxxxx-1-xx

Xxxxxxxx

3,4,5-xxxxxxxxxxxxxxxxxxxxxxx

Xxxxxxxxxxxx

Xxxxxxx

(2XX)-1-xxxxx-2-(xxxxxxxxxxx)xxxxxx-1-xx

3-XXX

2-(xxxxxxxxxxx(-1-(3-xxxxxXxxxxx)xxxxxx-1-xx

Xxxxxxxxxxxxxxxxxxx

XXXX

(2XX)-1-[5-xxxxxxx-3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx

Xxxxxxxxxxxxxx

(±)-5-xxxxx-4-xxxxxx-4,5-xxxxxxxxxxxxx-2-xxxxx

Xxxxxxxxxxxxxxxxxx

XXXX

(2XX)-X-xxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx

3-XxX-XXX

1-[1-(3-xxxxxxxxxxxxx)xxxxxxxxxx]xxxxxxxxx

xxxxxxxxxxxxx

2-(xxxxxxxxxx)-2-(3-xxxxxxxxxxxx)xxxxxxxxxxxx

Xxxxxxxx

2-(xxxxxxxxxxx)-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-1-xx

XX-45

1-xxxxxxxxxx-4-(1,2-xxxxxxxxxxxx)-xxxxxxxxx

Xxxxxxxxxxxxxxxxxxx

4-XXX

(2XX)-1-[4-(xxxxxXxxxxxxxx)xxxxx]xxxxxx-2-xxxx

Xxxxxxx

1-(xxxxxxxx-2-xx)-2-(xxxxxxxxxx-1-xx)xxxxxx-1-xx

Xxxxxxxxxxxxxxxxx

XXX, XXXX

(2XX)-X-xxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxxxxxxxxx-2-xxxx

Xxxxxxxxxxxxxxxxxxx

(2XX)-X-xxxxxxx-1-[3,4-(xxxxxxxxxxxxx)xxxxx]xxxxxx-2-xxxx

Xxxxxxxxxx

3-xxxxx-6,6,9-xxxxxxxxx-7,8,9,10-xxxxxxxxxx-6X-xxxxx[x]xxxxxxx-1-xx

xxxxxxxxx

1-xxxxx-2-(xxxxxxxxxxxx)xxxxxx-1-xx

xXXX

1-(4-xxxxxxxxxx)xxxxxxxxx

Xxxxxxxxxxxxxxxx

XXX

(2XX)-1-(4-xxxxxxxxxxxx)xxxxxx-2-xxxx

Xxxxxxxxxxxxxxxxxxx

XXXX

1-(4-xxxxxxxxxxxx)-X-xxxxxxxxxxxx-2-xxxx

Xxxxxxxxxx

3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx-xxxxxxxxxx-xxxxxx

Xxxxxxxx

Xxxxxxxxx

3-[2-(xxxxxxxxxxxxx)xxxxx]-1X-xxxxx-4-xx

Xxxxxxxxxxxx

XXX, XXXX

1-(1-xxxxxxxxxxxxxxx)xxxxxxxxxx

α-XXX

1-xxxxx-2-(xxxxxxxxxx-1-xx)-1-xxxxxx-1-xx

Xxxxxxxxxx X

xxxxxx-(2XX,4xX,6xX,7X,9XX,10xXX,10xX)-9-xxxxxxx-2-(xxxxx-3-xx)-6x, 10x-xxxxxxxx-4,10-xxxxxxxxxxxxxxxx-1X-xxxxx[x]xxxxxxxxxx-7-xxxxxxxxxx

Xxxxxxxxxxxxxxxxxxxxx

XXX, DOM

(2RS)-1-(2,5-dimethoxy-4-methylfenyl]propan-2-amin

Tenamfetamin

MDA

(2RS)-1-[3,4-(methylendioxy)fenyl]propan-2-amin

Tenocyklidin

TCP

1-[1-(2-thienyl)cyklohexyl]piperidin

TFMPP

1-[3-(trifluormethyl)fenyl]piperazin

Tetrahydrokanabinol

THC

Δ6a(10a)-,Δ6a(7)-,Δ7-,Δ8-,Δ10-,Δ9(11)-tetrahydrokanabinoly x xxxxxx xxxxxxxxxxxxx

Xxxxxxxxxxxxxxxxxxx

XXX

(2XX)-1-(3,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx

Xxxxxxxxxxxxxxxxxxx-2

XXX-2

(2XX)-1-(2,4,5-xxxxxxxxxxxxxxx)xxxxxx-2-xxxx

XX-144

(1-xxxxxx-1X-xxxxx-3-xx)-(2,2,3,3-xxxxxxxxxxxxxxxxxxxxxx)xxxxxxxx

Xxxxxx xxxxxxxxxxxxx psychotropních látek, xx xx xxxxxxxx xxxxxxx, uvedených v xxxxx seznamu xx xxxxx xxxxxxxxx, xxx xxxx stereaizomery mohou xxxxxxxxx podle xxxxxxxxxx xxxxxxxxxx označení a xxxx xxxxxxxxxxxxxx xxxxx xxxxxxxxx v tomto xxxxxxx xx všech xxxxxxxxx, xxx xxxxx xxxxxxxxx.".

Xx. XX

Xxxx xxxxxxxx xxxx oznámeno v xxxxxxx se xxxxxxxx Xxxxxxxxxx parlamentu a Xxxx 98/34/ES xx xxx 22. června 1998 o xxxxxxx xxx poskytování xxxxxxxxx x oblasti norem x xxxxxxxxxxx xxxxxxxx x xxxxxxxx xxx xxxxxx xxxxxxxxxx společnosti, x xxxxxxx znění.

Xx. XXX

Xxxxxxxx

Xxxx xxxxxxxx xxxxxx účinnosti xxxx 1. xxxxx 2015.

&xxxx;

Xxxxxxxx xxxxx:

Xxx. Xxxxxxx x. x.

&xxxx;

Xxxxxxx xxxxxxxxxxxxx:

XXXx. Xxxxxxx, XXX, x. r.

Xxxxxxxxx

Xxxxxx xxxxxxx č. 243/2015 Xx. xxxxx xxxxxxxxx xxxx 1.10.2015.

Xxxxx xxxxxxxxxxxx xxxxxxxx xxxxx xxxxxx právních xxxxxxxx x xxxxxxxx xxxx xxxxxxxxxxxxx, xxxxx xx xxxx xxxxxx xxxxxxxxx xxxxx shora xxxxxxxxx xxxxxxxx xxxxxxxx.